Cargando…

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III

Cardiovascular disease (CVD) is an evolving process that begins in the early stages of chronic kidney disease (CKD) in children. Several surrogate markers, such as ambulatory blood pressure monitoring (ABPM), left ventricular (LV) mass, and arterial stiffness assessment, allow for the early detectio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wei-Ling, Tain, You-Lin, Chen, Hung-En, Hsu, Chien-Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8397580/ https://www.ncbi.nlm.nih.gov/pubmed/34458211 http://dx.doi.org/10.3389/fped.2021.706323

Ejemplares similares

Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies
por: Dib, Israa, et al.
Publicado: (2021)

Diagnostic value of apolipoprotein C-I, transthyretin and apolipoprotein C-III in gastric cancer
por: Wang, Min, et al.
Publicado: (2019)

The Association Between Changes in Plasma Short-Chain Fatty Acid Concentrations and Hypertension in Children With Chronic Kidney Disease
por: Lu, Pei-Chen, et al.
Publicado: (2021)

Apolipoprotein E in VLDL and LDL With Apolipoprotein C‐III is Associated With a Lower Risk of Coronary Heart Disease
por: Mendivil, Carlos O., et al.
Publicado: (2013)

Distinct patterns of apolipoprotein C-I, C-II, and C-III isoforms are associated with markers of Alzheimer’s disease
por: Hu, Yueming, et al.
Publicado: (2020)

Apolipoprotein A-II Influences Apolipoprotein E-Linked Cardiovascular Disease Risk in Women with High Levels of HDL Cholesterol and C-Reactive Protein
por: Corsetti, James P., et al.
Publicado: (2012)

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
por: Tardif, Jean-Claude, et al.
Publicado: (2022)

Amyloid Triangles, Squares, and Loops of Apolipoprotein C-III
por: de Messieres, Michel, et al.
Publicado: (2014)

Apolipoprotein C-III in patients with systemic lupus erythematosus
por: Martín-González, Candelaria, et al.
Publicado: (2022)

Association of apolipoproteins C-I, C-II, C-III and E with coagulation markers and venous thromboembolism risk
por: Orsi, Fernanda A, et al.
Publicado: (2019)

Cardiovascular Risks of Hypertension: Lessons from Children with Chronic Kidney Disease
por: Tain, You-Lin, et al.
Publicado: (2022)

Apolipoprotein C‐III predicts cardiovascular events and mortality in individuals with type 1 diabetes and albuminuria
por: Jansson Sigfrids, Fanny, et al.
Publicado: (2021)

Pregnancy Zone Protein as an Emerging Biomarker for Cardiovascular Risk in Pediatric Chronic Kidney Disease
por: Chen, Wei-Ling, et al.
Publicado: (2023)

Effects of CETP inhibition with anacetrapib on metabolism of VLDL-TG and plasma apolipoproteins C-II, C-III, and E
por: Millar, John S., et al.
Publicado: (2017)

Apolipoprotein E Genotype and Cardiovascular Diseases in the Elderly
por: Haan, Mary N., et al.
Publicado: (2010)

Complement Factor H and Related Proteins as Markers of Cardiovascular Risk in Pediatric Chronic Kidney Disease
por: Liao, Wei-Ting, et al.
Publicado: (2022)

Production of Apolipoprotein C-III Knockout Rabbits using Zinc Finger Nucleases
por: Yang, Dongshan, et al.
Publicado: (2013)

Apolipoprotein E gene polymorphism and renal function are associated with apolipoprotein E concentration in patients with chronic kidney disease
por: Czaplińska, Monika, et al.
Publicado: (2019)

Overexpression of apolipoprotein C‐III decreases secretion of dietary triglyceride into lymph
por: Wang, Fei, et al.
Publicado: (2014)

The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides
por: Yassine, Hussein N., et al.
Publicado: (2015)

The emerging role of apolipoprotein C-III: beyond effects on triglyceride metabolism
por: Luo, Mengdie, et al.
Publicado: (2016)

The association of apolipoprotein B with chronic kidney disease in the Chinese population
por: Xu, Yu, et al.
Publicado: (2023)

Apolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?
por: Yang, Ning, et al.
Publicado: (2015)

Apolipoprotein C3 Is Downregulated in Patients With Inflammatory Bowel Disease
por: Hernández-Camba, Alejandro, et al.
Publicado: (2022)

Apolipoprotein C3 and apolipoprotein B colocalize in proximity to macrophages in atherosclerotic lesions in diabetes
por: Kanter, Jenny E., et al.
Publicado: (2020)

Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease
por: Dai, Wen, et al.
Publicado: (2019)

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
por: Mahley, Robert W.
Publicado: (2016)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
por: Ceci, Flavio M., et al.
Publicado: (2021)

Dose-Dependent Effect of Rosuvastatin on VLDL–Apolipoprotein C-III Kinetics in the Metabolic Syndrome
por: Ooi, Esther M.M., et al.
Publicado: (2008)

Apolipoproteins A-I, B, and C-III and Obesity in Young Adult Cherokee
por: Wang, Wenyu, et al.
Publicado: (2017)

Determinants of Statural Growth in European Children With Chronic Kidney Disease: Findings From the Cardiovascular Comorbidity in Children With Chronic Kidney Disease (4C) Study
por: Behnisch, Rouven, et al.
Publicado: (2019)

The Association between Nitric Oxide Pathway, Blood Pressure Abnormalities, and Cardiovascular Risk Profile in Pediatric Chronic Kidney Disease
por: Hsu, Chien-Ning, et al.
Publicado: (2019)

Apolipoprotein M
por: Luo, Guanghua, et al.
Publicado: (2004)

Effect of Aerobic Exercise on Risk Factors of Cardiovascular Disease and the Apolipoprotein B / Apolipoprotein A-1 Ratio in Obese Woman
por: Kim, Dae-Young, et al.
Publicado: (2014)

Urinary Apolipoprotein C3 Is a Potential Biomarker for Alzheimer's Disease
por: Watanabe, Yumi, et al.
Publicado: (2020)

Apolipoprotein C-III as a Potential Modulator of the Association Between HDL-Cholesterol and Incident Coronary Heart Disease
por: Jensen, Majken K., et al.
Publicado: (2012)

Interactions of the apolipoprotein C-III 3238C>G polymorphism and alcohol consumption on serum triglyceride levels
por: Ruixing, Yin, et al.
Publicado: (2010)

Detection of apolipoprotein C in human and rat enterocytes
Publicado: (1980)

Apolipoprotein E and Alzheimer's disease
por: Troutwine, Benjamin R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_utp81lj2h5d9aug98htiqet5s2